ATE301469T1 - Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase - Google Patents

Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase

Info

Publication number
ATE301469T1
ATE301469T1 AT01913407T AT01913407T ATE301469T1 AT E301469 T1 ATE301469 T1 AT E301469T1 AT 01913407 T AT01913407 T AT 01913407T AT 01913407 T AT01913407 T AT 01913407T AT E301469 T1 ATE301469 T1 AT E301469T1
Authority
AT
Austria
Prior art keywords
hyaluronidase
papain
vitamin
pharmaceutical
compound based
Prior art date
Application number
AT01913407T
Other languages
English (en)
Inventor
Santana Cristiano Albe Ribeiro
Nucci Gilberto De
Marcio Falci
Original Assignee
Topic Empreendimentos E Partic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Topic Empreendimentos E Partic filed Critical Topic Empreendimentos E Partic
Application granted granted Critical
Publication of ATE301469T1 publication Critical patent/ATE301469T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01913407T 2000-02-21 2001-02-20 Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase ATE301469T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0001144-4B1A BR0001144B1 (pt) 2000-02-21 2000-02-21 Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
PCT/BR2001/000019 WO2001060399A1 (en) 2000-02-21 2001-02-20 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase

Publications (1)

Publication Number Publication Date
ATE301469T1 true ATE301469T1 (de) 2005-08-15

Family

ID=3943888

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01913407T ATE301469T1 (de) 2000-02-21 2001-02-20 Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase

Country Status (11)

Country Link
US (1) US20030103955A1 (de)
EP (1) EP1299114B1 (de)
AT (1) ATE301469T1 (de)
AU (1) AU3903701A (de)
BR (1) BR0001144B1 (de)
CA (1) CA2399219C (de)
DE (1) DE60112578T2 (de)
ES (1) ES2244591T3 (de)
MX (1) MXPA02008116A (de)
PT (1) PT1299114E (de)
WO (1) WO2001060399A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0000426B1 (pt) * 2000-01-28 2014-09-30 Biolab Sanus Farmaceutica Ltda Composição farmacêutica
BR0006719A (pt) * 2000-05-04 2001-09-25 Cristiano Alberto Ribeiro Sant Composição em forma de creme, gel e creme gel aplicada na terapêutica da doença de peyronie, de colagenoses e patologias fibróticas à base de vitamina-e, papaìna 2% e hialuronidase
WO2003018063A1 (en) * 2001-08-27 2003-03-06 Medtopic Empreendimentos E Particapações S/C Ltda. Composition of a carrier substance for products based on papain and hyaluronidase
ES2223277B1 (es) * 2003-06-19 2006-03-01 Fernando Bouffard Fita Composicion anestesica para administracion topica.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2448903A1 (fr) * 1979-02-19 1980-09-12 Martin Henri Medicament nouveau a base d'agents antimicrobiens, d'enzymes, d'anti-inflammatoires, d'anesthesique local, d'agents keratolytiques, d'agents mucolytiques et d'au moins un emulsionnant
US4855142A (en) * 1987-02-27 1989-08-08 Ciba-Geigy Corporation Pharmaceutical plaster
US5296222A (en) * 1989-02-23 1994-03-22 University Of Utah Percutaneous drug delivery system
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
JP3765579B2 (ja) * 1990-08-24 2006-04-12 イーデーエーアー アーゲー 作用物質投与用超微小滴状調剤
US6165500A (en) * 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
DK42093D0 (da) * 1993-04-07 1993-04-07 Bukh Meditec Administrationsmetode
DE4313402A1 (de) * 1993-04-23 1994-10-27 Hexal Pharma Gmbh Transdermale Wirkstoffzubereitung
US5795916A (en) * 1994-08-09 1998-08-18 Tsumura & Co. Composition of external preparation

Also Published As

Publication number Publication date
BR0001144B1 (pt) 2013-10-22
PT1299114E (pt) 2005-11-30
US20030103955A1 (en) 2003-06-05
DE60112578T2 (de) 2006-05-24
AU3903701A (en) 2001-08-27
DE60112578D1 (de) 2005-09-15
EP1299114B1 (de) 2005-08-10
CA2399219A1 (en) 2001-08-23
MXPA02008116A (es) 2004-06-29
EP1299114A1 (de) 2003-04-09
ES2244591T3 (es) 2005-12-16
CA2399219C (en) 2013-04-09
BR0001144A (pt) 2001-11-27
WO2001060399A1 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
NO330947B1 (no) Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
BR0107869A (pt) Composições farmacêuticas eletrogiradas
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
BR0307893A (pt) Formulação oftálmica com sistema de goma
DE60038183D1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
NO20011471D0 (no) Nye orale vedvarende frigivelsesformuleringer
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
AU2845599A (en) Pharmaceutical compositions and their use
ID23806A (id) Komposisi-komposisi farmasi untuk pemberian oral yang terdiri dari bahan aktif dan siklodekstrin
HRP20010684B1 (hr) Izravno stlaciva matrica za kontrolirano otpustanje jednostruke dnevne doze klaritromicina
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
PL346764A1 (en) New oral formulation for 5-ht4
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
ATE268175T1 (de) Decursin-enthaltende pharmazeutische zusammensetzungen
DE60112578D1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
DE60005517D1 (de) Kaliumkanal-blockierende mittel
SE0001916D0 (sv) Novel formulation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1299114

Country of ref document: EP

REN Ceased due to non-payment of the annual fee